Browse studies

Find your next paid study

1 recruiting study matching your filters

ENCORE: Multicenter ProspectivE Registry of Sequential ANtibody Drug COnjugates (ADCs) in HER2 Negative Metastatic BREast Cancer (MBC)

Antibody-drug conjugates (ADCs) have demonstrated substantial improvement in progression free survival (PFS) and overall survival (OS) in phase III clinical tr…

HER2-negative Breast CancerHER2 Negative Breast CarcinomaMetastatic Breast Cancer+3 more

University of California, San FranciscoNCT06774027